We observed that MDM2 was amplified in 47 (27.8%) CRC tumors, and tumors with MDM2 amplification have significantly higher MDM2 mRNA expression (p=5.05×10-7, Figure 1A; Figure S1B and C). Here, MDM2 is linked to colorectal carcinoma.